NR4A1 Alleviates Subretinal Fibrosis by Inhibiting Macrophage to Myofibroblast Transition
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.6.47 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Rufei Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eye Hospital, First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Nuclear Receptor Subfamily 4, Group A, Member 1, Macrophages, Myofibroblasts. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Eye Hospital, First Affiliated Hospital of Harbin Medical University, Harbin, China.
- Key Laboratory of Hepatosplenic Surgery, Ministry of Education, First Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Ophthalmology, Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Zitieren
APA
Yang, R., Zong, T., Wang, N., Wang, F., & Su, Y. (2025). NR4A1 Alleviates Subretinal Fibrosis by Inhibiting Macrophage to Myofibroblast Transition. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.6.47
Vancouver
Yang R, Zong T, Wang N, Wang F, Su Y. NR4A1 Alleviates Subretinal Fibrosis by Inhibiting Macrophage to Myofibroblast Transition. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.6.47
BibTeX
@article{Yang2025,
author = {Yang, Rufei and Zong, Tingting and Wang, Ning and Wang, Feng and Su, Ying},
title = {NR4A1 Alleviates Subretinal Fibrosis by Inhibiting Macrophage to Myofibroblast Transition},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.6.47}
}
EUVIMED